Related Experiment Video
Updated: Jul 27, 2025

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
The common pathobiology between coronary artery disease and calcific aortic stenosis: Evidence and clinical
Toufik Abdul-Rahman1, Ileana Lizano-Jubert2, Neil Garg3
1Medical Institute, Sumy State University; Toufik's World Medical Association, Sumy, Ukraine.
Insights
Calcific aortic valve stenosis (CAS) and coronary artery disease (CAD) share atherosclerosis as a common mechanism. Understanding their links may improve treatments for both prevalent conditions.
Area of Science:
- Cardiovascular Medicine
- Pathology
Background:
- Calcific aortic valve stenosis (CAS) is the most common valvular disease globally.
- Coronary artery disease (CAD) is the third leading cause of death worldwide.
- CAS and CAD frequently coexist, sharing atherosclerosis as a primary underlying mechanism.
Purpose of the Study:
- To explore the shared pathogenesis and disparities between CAS and CAD.
- To review the etiology and risk factors common to both diseases.
- To discuss clinical implications and provide evidence-based management recommendations.
Main Methods:
- Literature review of studies on CAS and CAD.
- Analysis of shared etiological factors such as obesity, diabetes, metabolic syndrome, and lipid metabolism genes.
- Examination of common atherosclerotic pathways.
Main Results:
- Atherosclerosis is the central pathological process in both CAS and CAD.
- Shared risk factors including metabolic disturbances and genetic predispositions contribute to both conditions.
- CAS may serve as a potential marker for CAD due to their commonalities.
Conclusions:
- Understanding the commonalities between CAS and CAD is crucial for developing integrated therapeutic strategies.
- CAS and CAD management can benefit from addressing shared risk factors and pathological pathways.
- Further research into the interplay between CAS and CAD can optimize patient outcomes.
Abstract:
Calcific aortic valve stenosis (CAS), the most prevalent valvular disease worldwide, has been demonstrated to frequently occur in conjunction with coronary artery disease (CAD), the third leading cause of death worldwide. Atherosclerosis has been proven to be the main mechanism involved in CAS and CAD. Evidence also exists that obesity, diabetes, and metabolic syndrome (among others), along with specific genes involved in lipid metabolism, are important risk factors for CAS and CAD, leading to common pathological processes of atherosclerosis in both diseases. Therefore, it has been suggested that CAS could also be used as a marker of CAD. An understanding of the commonalities between the two conditions may improve therapeutic strategies for treating both CAD and CAS. This review explores the common pathogenesis and disparities between CAS and CAD, alongside their etiology. It also discusses clinical implications and provides evidence-based recommendations for the clinical management of both diseases.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Coronary Artery Disease III: Clinical Manifestations

